The Global Need for Long-Acting PrEP Among Key Populations

Forecasts of Global Demand 2025–2030

The introduction of long-acting PrEP represents a turning point in the global HIV response, especially for key populations who have historically faced persistent barriers to HIV prevention. Despite oral PrEP being introduced more than a decade ago, global uptake remains well below targets. New HIV infections are declining in some regions but are stagnating or rising in others, particularly where key populations are
underserved.

Also available on the GBGMC website.